ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "HONOR study"

  • Abstract Number: 2639 • ACR/ARHP Annual Meeting 2016

    Predicting Flare and Sustained Clinical Remission after Adalimumab Withdrawal Using the Multi-Biomarker Disease Activity (MBDA) Score

    Shintaro Hirata1, Xingbin Wang2, CC Hwang3, Ippei Miyagawa4, Satoshi Kubo1, Kazuhisa Nakano5, Shingo Nakayamada5, Kazuyoshi Saito4, Nadine A. Defranoux2 and Yoshiya Tanaka6, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2Crescendo Bioscience Inc., South San Francisco, CA, 3Biostatistics, Crescendo Bioscience Inc., South San Francisco, CA, 4University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 5First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 6University of Occupational and Environmental Health, Kitakyushu, Japan

    Background/Purpose: The multi-biomarker disease activity (MBDA) (Vectra® DA) score has been reported to predict disease relapses in patients with rheumatoid arthritis (RA) in sustained remission…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology